Subsequently, GBM cells were exposed to HMGB1 inhibitors with increasing concentrations, and the results demonstrated that HMGB1 inhibitor prominently downregulated the expression of TLR4, TREM2, phospho-Akt and Akt in a dose-dependent manner (Fig. 4G). Here, HMGB1 is linked to glioblastoma.